|
![]() |
![]() |
|||||||
| Supported by the Department for International Development, GlaxoSmithKline and the Bill & Melinda Gates Foundation | |||||||||
|
|||||||||
|
|
Lymphoedema
management knowledge and practices among patients attending filariasis
morbidity control clinics in Gampaha District, Sri Lanka Spatial
clustering of filarial transmission before and after a Mass Drug Administration
in a setting of low infection prevalence Willingness
to pay for prevention and treatment of lymphatic filariasis in Leogane,
Haiti Antibody
responses to Brugia malayi antigens induced by DNA vaccination Treatment
of co-infection with bancroftian filariasis and onchocerciasis: a safety
and efficacy study of albendazole with ivermectin compared to treatment
of single infection with bancroftian filariasis PCR
and Mosquito dissection as tools to monitor filarial infection levels
following mass treatment Obligatory
symbiotic Wolbachia endobacteria are absent from Loa loa Evidence
against Wolbachia symbiosis in Loa loa Mapping
of lymphatic filariasis in Nepal Human
immune responses to infective stage larval-specific chitinase of filarial
parasite, Onchocerca volvulus, Ov-CHI-1. Some
observations on the effect of Daflon (micronized purified flavonoid fraction
of Rutaceae aurantiae) in bancroftian filarial lymphoedema Animated
documentation of the filaria dance sign (FDS) in bancroftian filariasis Tolerability
and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC)
or co-administration of albendazole with DEC in the clearance of Wuchereria
bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry,
South India: a hospital-based study |
|
|||||||||||||||||||||||||||||
| |
||||||||||||||||||||||||||||||
| ©2006 Lymphatic Filariasis Support Centre |